Solve, BIO Online Conference Invites Biotech to Join In Fighting Long Covid
This article by Tom Popper originally appeared on Bio.com. While research into Long Covid is
February 14, 2023
This article by Tom Popper originally appeared on Bio.com. While research into Long Covid is
“Mild Covid-19 disease does not lead to serious or chronic long term morbidity in the
Solve M.E. supports research into the underlying causes of ME/CFS and Long Covid through the
Oxford-based biotech company PrecisionLife announced that their combinatorial analysis of genetic data links 14 genes
Last week, the PolyBio Research Foundation announced the launch of their Long Covid Research Initiative
Caroline Kingdon, RN, MSc, is a research nurse for CureME, an organization at the forefront
At Solve M.E., our advocacy team is dedicated to opening new funding avenues for ME/CFS,
The second episode of our three-part video series, Long Haul Voices, is available to view
Solve M.E. hosted special guest, Cecilia Dupecher, PhD Program Manager for PRMRP at the Congressionally
Solve M.E. is accepting applications to study ME/CFS and Long Covid from April 9 –
In survey, 30% of people with Long Covid said health improved after vaccination and 28%
In survey, 19% of people with ME/CFS said health worsened after vaccination compared to 4%
